InflaRx (IFRX) Equity Average (2017 - 2026)

InflaRx has disclosed Equity Average across 10 years of filings, most recently posting $45.8 million for Q1 2026.

• Equity Average for Q1 2026 came in at $45.8 million, down 34.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.8 million (down 34.48% YoY), and the FY2025 annual result was $57.0 million, down 35.23% from the prior year.
• Equity Average came in at $45.8 million for Q1 2026 at InflaRx, down from $50.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $132.1 million in Q3 2023 to a low of $45.8 million in Q1 2026.
• The 5-year median for Equity Average is $95.2 million (2022), against an average of $89.2 million.
• Across the five-year window, Equity Average advanced 26.25% in 2023 and plunged 42.5% in 2024, its largest moves.
• InflaRx's Equity Average stood at $95.2 million in 2022, then climbed by 25.43% to $119.4 million in 2023, then tumbled by 42.5% to $68.7 million in 2024, then declined by 26.15% to $50.7 million in 2025, then fell by 9.71% to $45.8 million in 2026.
• The last three Equity Average figures came in at $45.8 million (Q1 2026), $50.7 million (Q4 2025), and $58.8 million (Q3 2025), per Business Quant data.